Study: NCT00531284

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Administered by intravenous (IV) bolus (2-10 minute) infusion or 30 minute infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Administered orally or by IV infusion prior to carfilzomib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Administered orally or by IV infusion prior to carfilzomib